Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (6)
  • Parasite
    (2)
  • Retinoid Receptor
    (2)
  • Antibacterial
    (1)
  • Antibiotic
    (1)
  • Apoptosis
    (1)
  • CD38
    (1)
  • Cytochromes P450
    (1)
  • Dehydrogenase
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (9)
  • Metabolism
    (4)
  • Inflammation
    (3)
  • Immune System
    (2)
  • Infection
    (2)
Filter
Search Result
Results for "

T1491

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    12
    TargetMol | All_Pathways
  • Isotope Products
    1
    TargetMol | Isotope_Products
Atovaquone
Atavaquone
T149195233-18-4
Atovaquone (Atavaquone) is a hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.
  • $43
In Stock
Size
QTY
TargetMol | Citations Cited
Cdk1/2 Inhibitor III
T14914443798-55-8In house
Cdk1/2 Inhibitor III is a selective inhibitor of Cdk1/2 with an IC50 value of 2.1 μM against CDK1/cyclin B.
  • $123
In Stock
Size
QTY
CDK9-IN-2
T149181263369-28-3In house
CDK9-IN-2 is a specific CDK9 inhibitor with an IC50 of 5 nM in the A2058 skin cell line (72 hours) and 7 nM in the H929 multiple myeloma cell line (72 hours).
  • $80
In Stock
Size
QTY
CD161
NKR-P1A
T149101627716-22-6
CD161 is a potent, selective, and orally bioavailable BET bromodomain inhibitor (IC50s: 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2) with good anticancer activity.
  • $1,670
6-8 weeks
Size
QTY
CD2665
T14911170355-78-9
CD2665 is an orally active antagonist of retinoic acid receptor (RAR). For RARγ and RARβ, the Kis are 110 nM and 306 nM.
  • $40
In Stock
Size
QTY
CD3254
T14912196961-43-0
CD3254 is a selective and potent retinoid X receptor-like (RXR) agonist that inhibits neuronal cell death with OGD/reoxygenation.
  • $40
In Stock
Size
QTY
CD38 inhibitor 1
T149131700637-55-3
CD38 inhibitor 1 is a potent CD38 inhibitor that is effective against human CD38 (IC50 value is 7.3 nM) and mouse CD38 (IC50 value is 1.9 nM).
  • $51
In Stock
Size
QTY
CDK12-IN-E9
T149152020052-55-3
CDK12-IN-E9 is a cell cycle protein kinase (CDK) inhibitor with anticancer and antitumor activity that can be used in the study of breast cancer.
  • $132
In Stock
Size
QTY
CDK2-IN-4
T149162079895-42-2
CDK2-IN-4 is a potent and selective inhibitor of CDK2 with an IC50 of 44 nM for CDK2/cyclin A. It shows 2,000-fold selectivity over CDK1/cyclin B with IC50 of 86 uM.
  • $79
In Stock
Size
QTY
CDK8-IN-3
T149171884500-15-5
CDK8-IN-3 [CDK8-IN-3] is a potent and selective inhibitor of CDK8.
  • $1,110
8-10 weeks
Size
QTY
CDKI-73
T149191421693-22-2
CDKI-73 is a potent CDK9 inhibitor (Ki: 4 nM). It shows selective toxicity to CLL cells(LD50=80 nM) versus normal B cell and normal CD34+ cell(LD50>20 uM).The inhibition of CDK9 induces apoptosis and potentiates the effect of cisplatin.
  • $146
In Stock
Size
QTY
Atovaquone-D4
T191982070015-14-2
Atovaquone-D4 is the deuterium-labeled Atovaquone. Atovaquone (T1491) is a medication used to treat or prevent pneumocystis babesia, malaria, toxoplasmosis, and pneumonia.
  • $568
35 days
Size
QTY